Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.
about
Obesity-Related Chronic Kidney Disease-The Role of Lipid MetabolismTranscriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids: IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETESRenal outcomes of bariatric surgery in obese adults with diabetic kidney disease.FABP2 gene polymorphism and metabolic syndrome in elderly people of croatian descent.Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studiesEffect of Aging in the Perception of Health-Related Quality of Life in End-Stage Renal Disease Patients under Online-Hemodiafiltration.Adiposity patterns and the risk for ESRD in postmenopausal womenDrug Dosing and Pharmacokinetics in Children With Obesity: A Systematic ReviewSickle cell trait is not associated with chronic kidney disease in adult Congolese patients: a clinic-based, cross-sectional study.Effects of Bariatric Surgery on Renal Function in Obese Patients: A Systematic Review and Meta Analysis.Sex, weight status, and chronic kidney disease among African Americans: the Jackson Heart Study.DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes.RLIP76 protein knockdown attenuates obesity due to a high-fat dietRisk factors for mortality in hemodialysis patients: two-year follow-up study.Is there an obesity-related epidemic of CKD starting already in childhood?Treatment strategies to prevent renal damage in hypertensive children.Lung function and impaired kidney function in relation to metabolic syndrome.Effect of Different Obesity Phenotypes on Incidence of Chronic Kidney Disease in Tehranian Adults.Hypertension in pediatric patients with chronic kidney disease: management challenges.Glomerular homeostasis requires a match between podocyte mass and metabolic load.Patients with non-insulin depending diabetes mellitus and metabolic syndrome are suboptimal treated in Swiss primary care.Body mass index and resistance to recombinant human erythropoietin therapy in maintenance hemodialysis patients.Association between waist-to-height ratio and chronic kidney disease in the Taiwanese population.Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H: quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials.Predictors of health-related quality of life perceived by end-stage renal disease patients under online hemodiafiltration.The Efficacy of Crocin of Saffron (Crocus sativus L.) on the Components of Metabolic Syndrome: A Randomized Controlled Clinical Trial.Longitudinal relationships of metabolic syndrome and obesity with kidney function: Healthy Twin Study.Low carbohydrate diet is associated with reduced risk of metabolic syndrome in Tehranian adults.Long-term risk for end-stage kidney disease and death in a large population-based cohort.
P2860
Q26774143-004ADB64-AA97-4442-9E98-7E663FCC554DQ28269939-DA7BABEF-D30F-464D-A170-E81F1F982D21Q30360386-BCAD7CE1-DBE4-4BEE-91F1-700EAD73A3F2Q33773207-8FD00187-7DFA-4370-AA57-26A1E04B58F1Q34042891-184BF4E1-62E9-41B6-817D-17F53DC9F067Q35013331-5CFFD4A3-BFC1-44F1-ABE8-376961B7338CQ35051169-54CCC0A2-6958-4049-84E2-25A2AD3116B8Q35828378-CF246642-15B1-4170-8B33-4F7F587F9C39Q35962140-C8F095B1-5E3D-464D-9FC3-BB23AB7AA8FEQ36152742-CC772A83-0B0F-4507-848D-264D48AD08EDQ36887466-6CDBF9F5-0E77-4059-9633-5AEE92685D43Q37095161-6A3DAEE7-F6EA-4A13-AD81-0ADBA0EE9C5DQ37095458-4B4AE7E9-3484-47B7-BF92-ACC9F6D9794AQ37379663-0C58E887-5239-4DA6-8CAD-E24DC98D1D45Q38135268-3C7A3EAA-B768-4835-A67C-2598E25EF1F6Q38187597-4ED5D424-D538-4263-84E2-1D1DF24B2B31Q38904348-B580B1CC-7834-4AD7-B790-B54BF7195355Q40228971-27189AC7-4E6C-4F67-9219-3851A590AA51Q41200646-B52E6483-0296-439C-ACA7-660AA263CDBBQ43229492-527823FF-5B77-4DD9-83E3-41D55F845A32Q43595780-B8C0D29D-586E-47AB-94A0-625E7758AA45Q44518155-08109222-FEB3-40C4-8096-A81CD5C1585BQ44931863-CB312F14-369E-49FA-AD6C-F2723D02C0DBQ46046912-7074EEB0-9CAA-4058-A9FB-0F02F424B774Q46155646-C36E5C66-AB63-42CE-A88E-976A4936FE69Q50054592-4345E3FB-AFAA-4304-BDB4-E9C320DF7363Q50967646-386B330A-D99E-4140-A47F-934D2D29A0DAQ51278190-97D001D7-1ACE-4883-9520-C7A4427EFD06Q55223580-29A0814E-10F6-42FB-A789-7408D28D7C51
P2860
Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.
@en
Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.
@nl
type
label
Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.
@en
Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.
@nl
prefLabel
Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.
@en
Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.
@nl
P2093
P2860
P921
P1476
Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.
@en
P2093
Paul Muntner
Rikki M Tanner
Todd M Brown
P2860
P2888
P304
P356
10.1007/S11906-012-0254-Y
P577
2012-04-01T00:00:00Z